Universal Vision Valuation Multiples

Discover revenue and EBITDA valuation multiples for Universal Vision and similar public comparables like Standard BioTools, SmartVest, Medios, Advanced Technology Company and more.

Universal Vision Overview

About Universal Vision

Universal Vision Biotechnology Co Ltd is mainly engaged in operating the business of sales of optical devices, glasses, lenses, and other vision aid products; optometric services; sales and leasing of medical devices; and providing hospital management and technical consultancy services. The company's reportable segments include its Ophthalmology Business segment and the Optometry Business segment. A majority of its revenue is generated from the Ophthalmology Business segment, which is responsible for providing ophthalmic clinics and hospital technical services and consultancy services, and leasing services. The Optometry Business segment is responsible for the sales of glasses and peripheral equipment. Geographically, the company derives maximum revenue from Taiwan and the rest from China.


Founded

1994

HQ

Taiwan

Employees

325

Website

uvb.com.tw

Financials (LTM)

Revenue: $134M
Net Income: $34M

EV

$318M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Universal Vision Financials

Universal Vision reported last 12-month revenue of $134M.

In the same LTM period, Universal Vision generated $34M in net income.

Revenue (LTM)


Universal Vision P&L

In the most recent fiscal year, Universal Vision reported revenue of $131M and EBITDA of $59M.

Universal Vision is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 45%, and net margin of 25%.

See analyst estimates for Universal Vision
LTMLast FY202320242025202620272028
Revenue$134M$131M$126M$131M$130M
Gross Profit-$77M$76M$78M$77M
Gross Margin-58%60%60%59%
EBITDA-$59M$55M$57M$59M
EBITDA Margin-45%44%44%46%
EBIT Margin33%33%32%33%33%
Net Profit$34M$32M$32M$33M$32M
Net Margin25%25%26%25%25%

Financial data powered by Morningstar, Inc.

Universal Vision Stock Performance

Universal Vision has current market cap of $350M, and enterprise value of $318M.

Market Cap Evolution


Universal Vision's stock price is $4.14.

Universal Vision share price decreased by 3.8% in the last 30 days, and by 34.6% in the last year.

Universal Vision has an EPS (earnings per share) of $0.38.

See more trading valuation data for Universal Vision
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$318M$350M-0.4%-3.8%-3.8%-34.6%$0.38

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Universal Vision Valuation Multiples

Universal Vision trades at 2.4x EV/Revenue multiple, and 5.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Universal Vision

EV / Revenue (LTM)


Universal Vision Financial Valuation Multiples

As of July 19, 2026, Universal Vision has market cap of $350M and EV of $318M.

Universal Vision has a P/E ratio of 10.3x.

LTMLast FY202320242025202620272028
EV/Revenue2.4x2.4x2.5x2.4x2.5x
EV/EBITDA-5.4x5.8x5.5x5.4x
EV/EBIT7.2x7.4x7.8x7.4x7.5x
EV/Gross Profit-4.2x4.2x4.1x4.2x
P/E10.3x10.8x10.9x10.7x10.9x
EV/FCF12.1x9.1x9.6x8.4x9.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Universal Vision Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Universal Vision Margins & Growth Rates

Universal Vision grew revenue by 4% and net profit by 9% in the last fiscal year.

In the most recent fiscal year, Universal Vision reported gross margin of 58%, EBITDA margin of 45%, and net margin of 25%.

See estimated margins and future growth rates for Universal Vision

Universal Vision Margins

Last FY202420252026202720282029
Gross Margin58%60%59%-
EBITDA Margin45%44%46%-
EBIT Margin33%33%33%33%
Net Margin25%25%25%26%
FCF Margin27%29%26%14%

Universal Vision Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%4%(1%)5%
Gross Profit Growth-3%(2%)-
EBITDA Growth-4%3%-
EBIT Growth5%6%(2%)6%
Net Profit Growth9%2%(2%)10%
FCF Growth(46%)14%(11%)(44%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Universal Vision Operational KPIs

Universal Vision's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Universal Vision
Last FY202320242025202620272028
Revenue per Employee$0.4M---
Opex per Employee$0.1M---
S&M Expenses to Revenue16%17%17%17%
G&A Expenses to Revenue10%10%10%10%
Opex to Revenue26%28%27%26%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Universal Vision Competitors

Universal Vision competitors include Standard BioTools, SmartVest, Medios, Advanced Technology Company, Perspective Therapeutics, CellaVision, Abbott Pakistan, CapsoVision, NIOX Group and TaiDoc Technology.

Most Universal Vision public comparables operate across Medical Devices, Medical Supplies, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Standard BioTools(0.9x)(0.9x)1.2x2.0x
SmartVest5.2x4.5x23.7x18.8x
Medios0.2x0.2x4.7x4.6x
Advanced Technology Company1.9x-150.0x-
Perspective Therapeutics84.0x122.9x(0.7x)(0.6x)
CellaVision4.2x4.3x13.2x14.3x
Abbott Pakistan1.1x-5.2x-
CapsoVision23.5x21.7x(12.8x)-

This data is available for Pro users. Sign up to see all Universal Vision competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Universal Vision

When was Universal Vision founded?Universal Vision was founded in 1994.
Where is Universal Vision headquartered?Universal Vision is headquartered in Taiwan.
How many employees does Universal Vision have?As of today, Universal Vision has over 325 employees.
Is Universal Vision publicly listed?Yes, Universal Vision is a public company listed on Taipei Exchange.
What is the stock symbol of Universal Vision?Universal Vision trades under 3218 ticker.
When did Universal Vision go public?Universal Vision went public in 2004.
Who are competitors of Universal Vision?Universal Vision main competitors include Standard BioTools, SmartVest, Medios, Advanced Technology Company, Perspective Therapeutics, CellaVision, Abbott Pakistan, CapsoVision, NIOX Group, TaiDoc Technology.
What is the current market cap of Universal Vision?Universal Vision's current market cap is $350M.
What is the current revenue of Universal Vision?Universal Vision's last 12 months revenue is $134M.
What is the current revenue growth of Universal Vision?Universal Vision revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of Universal Vision?Current revenue multiple of Universal Vision is 2.4x.
What is the current net income of Universal Vision?Universal Vision's last 12 months net income is $34M.
What is the current FCF of Universal Vision?Universal Vision's last 12 months FCF is $26M.
What is Universal Vision's FCF margin?Universal Vision's last 12 months FCF margin is 20%.
What is the current EV/FCF multiple of Universal Vision?Current FCF multiple of Universal Vision is 12.1x.
How many companies Universal Vision has acquired to date?Universal Vision hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Universal Vision has invested to date?Universal Vision hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Universal Vision

Lists including Universal Vision

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial